88918-72-3

Basic information

• Product Name: Benzenemethanesulfonamide, 4-nitro-
• CAS NO: 88918-72-3
• Molecular Formula: C7H8N2O4S
• Molecular Weight: 216.218
• Mol File: 88918-72-3.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Benzenemethanesulfonamide, 4-nitro-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanesulfonamide, 4-nitro-(88918-72-3)
• EPA Substance Registry System: Benzenemethanesulfonamide, 4-nitro-(88918-72-3)

Safety Data

• Hazardous Substances Data: 88918-72-3(Hazardous Substances Data)

Usage

Sulfonamide derivative

A compound containing a sulfonamide functional group

Nitro group attached to benzene ring

A nitro group (-NO2) is attached to a benzene ring in the molecule

Intermediate/reagent

Used in the synthesis of various pharmaceuticals and organic compounds

Studied for biological/pharmacological activities

Including antibacterial and antifungal properties

Skin and eye irritant

Should be handled with caution in laboratory and industrial settings

Upstream product

• 100-44-7 benzyl chloride 
• 100-87-8 Benzylsulfonic acid 
• 36639-50-6 Sodium 4-nitrobenzylsulphonate 
• 4563-33-1 phenyl-methanesulfonic acid amide 
• 4025-75-6 (4-nitrophenyl)methanesulfonyl chloride 
• 53992-33-9 (4-nitrophenyl)-methanesulfonic acid 

Downstream Products

• 91647-24-4 3-(4-Nitro-benzylsulfonyl)-1-butyl-harnstoff 
• 165669-09-0 4-(sulfamoylmethyl)benzenesulfonyl chloride 
• 62-23-7 4-nitro-benzoic acid 
• 4403-84-3 4-Aminobenzenemethanesulphonamide 
• 110654-58-5 1,3,5-Tris-(4-nitro-phenylmethanesulfonyl)-[1,3,5]triazinane 

Relevant articles and documents

STRAD-BINDING AGENTS AND USES THEREOF

Disclosed herein, inter alia, are compounds for binding STRAD pseudokinase and uses thereof.

INHIBITORS OF PROTEIN KINASES

The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).

INHIBITORS OF PROTEIN KINASES

The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).